Navigation Links
St. Jude Scientist Named Pew Scholar
Date:6/16/2009

Charles Mullighan, M.D., Ph.D., becomes fourth St. Jude scientist honored

MEMPHIS, Tenn., June 16 /PRNewswire-USNewswire/ -- Charles Mullighan, M.D., Ph.D., an assistant member in the Pathology Department at St. Jude Children's Research Hospital, has been named a 2009 Pew Scholar in the Biomedical Sciences.

Selected by The Pew Charitable Trusts as one of 17 of the country's most promising early-career scientists, Mullighan will receive a $240,000 award over four years to support his research.

"Dr. Mullighan's appointment as a Pew Scholar is further validation of his remarkable accomplishments at this early stage in his career and the potential he has as a physician-scientist to make major discoveries in the future," said Dr. William E. Evans, St. Jude director and CEO. "We are fortunate to have Dr. Mullighan as one of a strong group of junior faculty who ensure the future success of St. Jude."

Mullighan's research focuses on the use of high-resolution, genome-wide approaches to identify genomic aberrations contributing to leukemogenesis and influencing leukemia outcome; the use of in vitro and in vivo experimental approaches to model genomic abnormalities in leukemogenesis; and the genetics of disease susceptibility and disease phenotype, most notably the genetic determinants of allogeneic hematopoietic stem cell transplant outcome.

"Being named a Pew Scholar is a tremendous honor and will provide very important support at this stage of my career," Mullighan said. "The award also reflects the exceptional research environment at St. Jude that has enabled the work recognized by the scholarship to be performed."

Pew Scholars are junior faculty members at medical schools and research institutions who show outstanding promise in research that is related to the advancement of human health.

A native of Adelaide, Australia, Mullighan attended medical school at the University of Adelaide, earning a Bachelor of Medicine and Bachelor of Surgery with honors in 1993. He received a Master of Science from the University of London in 1997; and earned a Doctor of Medicine from the University of Adelaide in 1998.

Mullighan is a fellow of the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia. In 2004, he joined the staff at St. Jude as a postdoctoral fellow in Pathology and was named an assistant member in the department in May 2008. Mullighan is also the recipient of the prestigious American Society of Hematology Merit and Scholar awards.

Brenda Schulman, Ph.D., a member of Structural Biology and Genetics/Tumor Cell Biology at St. Jude, became the hospital's first Pew Scholar in 2002. Michael Dyer, Ph.D., a member of Developmental Neurobiology at St. Jude, received the distinction in 2004, and Joseph Opferman, Ph.D., an assistant member of Biochemistry, was honored in 2006.

In its 25th year, the Pew Scholars Program in the Biomedical Sciences has invested more than $125 million to support more than 460 scholars. Previous scholars have gone on to win the Nobel Prize, MacArthur Award Fellowships and the Albert Lasker Medical Research Award.

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and based in Memphis, Tenn., St. Jude freely shares its discoveries with scientific and medical communities around the world. No family ever pays for treatments not covered by insurance, and families without insurance are never asked to pay. St. Jude is financially supported by ALSAC, its fundraising organization. For more information, please visit www.stjude.org.


'/>"/>
SOURCE St. Jude Children's Research Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. 17 of Americas Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences
2. CEL-SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annual Aseptic Processing of Sterile Drug Products Conference
3. Scientists advance safety of nanotechnology
4. UNC scientists identify growth factor as possible cancer drug target
5. World first: Chinese scientists create pig stem cells
6. Scientists use bed bugs own chemistry against them
7. NYP/Weill Cornell physician-scientists present at 2009 American Transplant Congress in Boston
8. Scripps Florida scientists devise accelerated method to determine infectious prion strains
9. Berkeley Lab scientist co-leads breast cancer dream team
10. Scientists find city rats are loyal to their hoods
11. Scientists find shared genetic link between the dental disease periodontitis and heart attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... ... January 13, 2017 , ... The 18th European Congress: Perspectives in Lung ... 3-4, 2017. This Congress is expertly designed to meet the educational needs of ... lung cancer. , Chaired by Dr. Giorgio V. Scagliotti, Professor of Oncology at the ...
(Date:1/13/2017)... Princeton, NJ (PRWEB) , ... January 13, 2017 , ... ... of sale companions, will be showcasing the next generation companion scanner and data collector ... City. The new KDC270 has been created as an answer to the market’s need ...
(Date:1/13/2017)... PITTSBURGH, PA (PRWEB) , ... January 13, 2017 , ... An inventor from Pahrump, Nev., ... many others. "My urologist had me wear a Foley catheter and urine bag for a ... difficult and uncomfortable, so I decided that there should be a better way to do ...
(Date:1/13/2017)... ... January 13, 2017 , ... People who have sensitive ... of pain whenever they brush their teeth. Sadly, most dental hygiene products in the ... gums and teeth. For these people, continuing their daily oral care routine to keep ...
(Date:1/13/2017)... ... January 13, 2017 , ... Friday, January 13 at 5 pm, America’s Incredible ... the size of the location to 90,000 square feet. , Included in the expansion ... takes customers on an educational tour of the historic route, with each hole in ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... Tenn. , Jan. 16, 2017  Cumberland Pharmaceuticals ... of Kenneth J. Krogulski , CFA to its ... Executive Officer of Berkshire Asset Management LLC . ... a 30-year-old independent SEC registered investment advisory firm with ... has over 37 years, experience in security analysis and ...
(Date:1/15/2017)... Le conseil d,administration de SurgaColl Technologies Ltd., le ... régénération de tissus humains, annonce la nomination de William ... immédiat. ... Bill est un dirigeant expérimenté à l,international dans l,industrie des ... et de direction au sein de sociétés internationales spécialisées dans ...
(Date:1/13/2017)... 13, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: ... Corporate Finance and Investment Banking at Eli Lilly & Company, ... Mr. Bott brings over 28 years of senior financial and ... ... has established a significant leadership position in financial and ...
Breaking Medicine Technology: